BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oddone F, Rossetti L, Parravano M, Sbardella D, Coletta M, Ziccardi L, Roberti G, Carnevale C, Romano D, Manni G, Parisi V. Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review. Pharmaceuticals (Basel) 2021;14:281. [PMID: 33804675 DOI: 10.3390/ph14030281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Martucci A, Mancino R, Cesareo M, Pinazo-Duran MD, Nucci C. Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma. Front Med (Lausanne) 2022;9:1020993. [PMID: 36590976 DOI: 10.3389/fmed.2022.1020993] [Reference Citation Analysis]
2 Lambuk L, Suhaimi NAA, Sadikan MZ, Jafri AJA, Ahmad S, Nasir NAA, Uskoković V, Kadir R, Mohamud R. Nanoparticles for the treatment of glaucoma-associated neuroinflammation. Eye and Vis 2022;9:26. [DOI: 10.1186/s40662-022-00298-y] [Reference Citation Analysis]
3 Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE. Citicoline and COVID-19: vis-à-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 36063198 DOI: 10.1007/s00210-022-02284-6] [Reference Citation Analysis]
4 Marchesi N, Fahmideh F, Barbieri A, Racchi M, Pascale A, Govoni S. Pharmacological Versus Non-Pharmacological and Ancillary Mechanisms in Eye Drops Used in the Treatment of Glaucoma. Front Drug Saf Regul 2022;2. [DOI: 10.3389/fdsfr.2022.933471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Persico M, Santoro AM, D’urso A, Milardi D, Purrello R, Cunsolo A, Gobbo M, Fattorusso R, Diana D, Stefanelli M, Tundo GR, Sbardella D, Coletta M, Fattorusso C. Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution. Biomolecules 2022;12:741. [DOI: 10.3390/biom12060741] [Reference Citation Analysis]
6 Fragiotta S, Pinazo-durán MD, Scuderi G. Understanding Neurodegeneration from a Clinical and Therapeutic Perspective in Early Diabetic Retinopathy. Nutrients 2022;14:792. [DOI: 10.3390/nu14040792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Turana Y, Nathaniel M, Shen R, Ali S, Aparasu RR. Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications. Brain Sciences 2022;12:59. [DOI: 10.3390/brainsci12010059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Amato R, Rossino MG, Cammalleri M, Timperio AM, Fanelli G, Dal Monte M, Pucci L, Casini G. The Potential of Lisosan G as a Possible Treatment for Glaucoma. Front Pharmacol 2021;12:719951. [PMID: 34393798 DOI: 10.3389/fphar.2021.719951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Vernazza S, Oddone F, Tirendi S, Bassi AM. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention. Int J Mol Sci 2021;22:7994. [PMID: 34360760 DOI: 10.3390/ijms22157994] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Parisi V, Ziccardi L, Barbano L, Giorno P, Varano M, Parravano M. Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 36-Month Pilot Study Evaluating Macular Electrophysiological Changes. Adv Ther 2021;38:3924-36. [PMID: 34091874 DOI: 10.1007/s12325-021-01771-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]